SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHydrogenOne Regulatory News (HGEN)

  • There is currently no data for HGEN

Portfolio Update - HH2E

8 Nov 2024 07:00

RNS Number : 4422L
HydrogenOne Capital Growth PLC
08 November 2024
 

LEI: 213800PMTT98U879SF45

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

 

8 November 2024

 

HydrogenOne Capital Growth plc

("HydrogenOne" or the "Company")

 

Portfolio Update - HH2E

 

HydrogenOne, the first London-listed fund investing in clean hydrogen for a positive environmental impact, updates on HH2E AG ("HH2E"), a German green hydrogen project developer.

 

HH2E has been undertaking a fundraising exercise in order to go ahead with its first development project, at Lubmin. However, in the challenging current global funding environment, the process has not led to a financing partner being secured within the required timeframe and at the required scale, and there is now material uncertainty over whether adequate funding will be achieved. The Company now expects these developments to result in HH2E entering administration.

 

HH2E's administration process will focus on an outcome in the interests of all creditors. HydrogenOne is a creditor and has provided c. £1 million shareholder loans to HH2E. Under German insolvency law, shareholder loans are subordinated to other creditors.

 

The outcome of the administration process is not yet known, but the Company will update the market further at the appropriate time.

 

At 30 September 2024, the Company's unaudited NAV for HH2E was £11 million representing 8% of the Company's NAV.

 

- Ends -

 

Notes

For further information, please visit www.hydrogenonecapitalgrowthplc.com or contact:

 

HydrogenOne Capital LLP - Investment Adviser

+44 (0) 20 3830 8231

Dr. JJ Traynor

Richard Hulf

Eva Bezruchko

 

 

Barclays Bank PLC - Corporate Broker

Dion Di Miceli

Stuart Muress

James Atkinson

 

+44 (0) 20 7623 2323

BarclaysInvestmentCompanies@barclays.com

 

Burson Buchanan - Public Relations

Henry Harrison-Topham

Henry Wilson

George Beale

+44 (0) 20 7466 5000

HGEN@buchanancomms.co.uk

 

 

About HydrogenOne:

 

HydrogenOne is the first London-listed hydrogen fund investing in clean hydrogen for a positive environmental impact. The Company was launched in 2021 with an investment objective to deliver an attractive level of capital growth by investing in a diversified portfolio of hydrogen and complementary hydrogen focussed assets. INEOS Energy is a strategic investor in HydrogenOne. The Company is listed on the London Stock Exchange's main market (ticker code: HGEN). The Company is an Article 9 climate impact fund with an ESG policy integrated in investment decisions and asset monitoring.

 

IMPORTANT NOTICE

 

This announcement does not constitute an offer to sell, or the solicitation of an offer to acquire or subscribe for, shares in the Company in any jurisdiction. The distribution of this announcement outside the UK may be restricted by law. No action has been taken by the Company that would permit possession of this announcement in any jurisdiction outside the UK where action for that purpose is required. Persons outside the UK who come into possession of this announcement should inform themselves about the distribution of this announcement in their particular jurisdiction.

This announcement contains (or may contain) certain forward-looking statements with respect to certain of the Company's plans and/or the plans of one or more of its investee companies or projects and their respective current goals and expectations relating to their respective future financial condition and performance and which involve a number of risks and uncertainties. The Company cautions readers that no forward- looking statement is a guarantee of future performance and that actual results could differ materially from those contained in the forward- looking statements.

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014, as it forms part of UK domestic law ("MAR"). Upon publication of this announcement, the inside information is now considered to be in the public domain for the purposes of MAR. The person responsible for arranging the release of this announcement on behalf of the Company is HydrogenOne Capital LLP. HydrogenOne Capital LLP (FRN: 954060) is an appointed representative of Thornbridge Investment Management LLP (FRN: 713859) which is authorised and regulated by the Financial Conduct Authority.

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFUFSUEFWELSEFF
Date   Source Headline
30th Jan 20237:00 amRNSNotice of quarterly portfolio, NAV and webinar
26th Jan 20237:00 amRNSInvestment in first green hydrogen project
17th Jan 20237:00 amRNSName Change of Administrator and Company Secretary
17th Jan 20237:00 amRNSNotice of Capital Markets Day
12th Jan 20237:00 amRNSChange of Adviser
15th Dec 20227:00 amRNS£1.1m investment in Strohm Holding B.V.
2nd Dec 20227:00 amRNSWebsite upgrade
16th Nov 20227:00 amRNSSFDR Article 9 Fund and PRI signatory
16th Nov 20227:00 amRNSQ3 2022 Factsheet and NAV update
15th Nov 20222:00 pmRNSNet Asset Value(s)
14th Nov 20222:00 pmRNSNet Asset Value(s)
11th Nov 20222:00 pmRNSNet Asset Value(s)
10th Nov 20222:00 pmRNSNet Asset Value(s)
9th Nov 20222:00 pmRNSNet Asset Value(s)
8th Nov 20222:00 pmRNSNet Asset Value(s)
7th Nov 20222:13 pmRNSNet Asset Value(s)
4th Nov 20222:00 pmRNSNet Asset Value(s)
3rd Nov 20222:00 pmRNSNet Asset Value(s)
3rd Nov 202211:50 amRNSHolding(s) in Company
3rd Nov 202211:50 amRNSChange of name of AIFM
3rd Nov 202211:09 amRNSCapital Markets Day Notification - Postponement
2nd Nov 20225:58 pmRNSHolding(s) in Company
2nd Nov 20225:35 pmRNSHolding(s) in Company
2nd Nov 20222:00 pmRNSNet Asset Value(s)
1st Nov 20222:00 pmRNSNet Asset Value(s)
31st Oct 20222:00 pmRNSNet Asset Value(s)
28th Oct 20222:00 pmRNSNet Asset Value(s)
27th Oct 20223:50 pmRNSNet Asset Value(s)
26th Oct 20222:24 pmRNSNet Asset Value(s)
25th Oct 20222:00 pmRNSNet Asset Value(s)
24th Oct 20222:34 pmRNSNet Asset Value(s)
21st Oct 20222:00 pmRNSNet Asset Value(s)
20th Oct 20222:00 pmRNSNet Asset Value(s)
19th Oct 20222:00 pmRNSNet Asset Value(s)
19th Oct 20221:17 pmRNSResult of Meeting
18th Oct 20222:00 pmRNSNet Asset Value(s)
17th Oct 20222:00 pmRNSNet Asset Value(s)
17th Oct 20222:00 pmRNSNet Asset Value(s)
17th Oct 202210:13 amRNSDirector Declaration
17th Oct 20227:00 amRNSCapital Markets Day
17th Oct 20227:00 amRNSCapital Markets Day
14th Oct 20222:00 pmRNSNet Asset Value(s)
13th Oct 20222:00 pmRNSNet Asset Value(s)
12th Oct 20222:00 pmRNSNet Asset Value(s)
11th Oct 20222:00 pmRNSNet Asset Value(s)
10th Oct 20221:00 pmRNSNet Asset Value(s)
7th Oct 20221:00 pmRNSNet Asset Value(s)
6th Oct 20221:31 pmRNSNet Asset Value(s)
5th Oct 20222:28 pmRNSNet Asset Value(s)
4th Oct 20222:00 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.